tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE

Gyre Therapeutics (GYRE) Stock Investors

792 Followers
Based on 732,319 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GYRE
On average, investors allocate 4.31% of their portfolios to GYRE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 732,319 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GYRE

0.5%
Last 7
Days
0.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GYRE, out of 732,319 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GYRE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.21%
$8.76
Reduced
0.00%
$23.79
Based on the activity of 13,788 investors who made their portfolios public
The table shows changes in GYRE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GYRE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
3.97%
-2.48%
-4.75%
753.58M
Consumer Cyclical
Marathon Digital Holdings
5.50%
-2.25%
-2.30%
5.84B
Financial
Plug Power
4.94%
-2.39%
-4.96%
1.89B
Industrials
Riot Platforms
5.04%
-1.51%
+1.88%
3.11B
Financial
Coherus Biosciences
2.64%
-2.66%
-6.73%
251.97M
Healthcare
AMC Entertainment
5.49%
-2.41%
-5.39%
909.32M
Communication Services
Blink Charging Co
5.11%
-2.66%
-6.23%
324.18M
Industrials
Merck & Company
4.13%
-1.51%
+0.37%
323.11B
Healthcare
GE Aerospace
5.48%
-0.80%
+6.73%
183.86B
Industrials
Block
4.36%
-1.34%
-3.96%
45.37B
Technology
Based on the activity of 732,319 active portfolios
Open your Smart Portfolio

GYRE Investor Analysis

GYRE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.9%
of GYRE holders
are under 35
Average Segment Performance
Average P/E Ratio52.24
Beta6.32
Dividend Yield6.28%
GYRE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.5%
of GYRE holders
are between 35–55
Average Segment Performance
Average P/E Ratio56.33
Beta11.09
Dividend Yield19.22%
GYRE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
34.6%
of GYRE holders
are over 55
Average Segment Performance
Average P/E Ratio47.15
Beta3.97
Dividend Yield6.60%
Overview of age group and performance of GYRE stock investors
See who invests in GYRE according to age group and performance.

FAQ

How many retail Investors hold GYRE?
<0.1% of TipRanks' retail investors hold GYRE in their portfolios.
    What is GYRE Investor Sentiment?
    GYRE’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of GYRE in the last 7 days?
      ▲ 0.5% of TipRanks' retail investors changed their holding of GYRE in the last 7 days.
        What percentage of retail investors changed their holding of GYRE in the last 30 days?
        ▼ 0.2% of TipRanks' retail investors changed their holding of GYRE in the last 30 days.
          What is the average age of retail investors who hold GYRE?
          The average age of GYRE Holders is between 35–55.
            What other stocks have GYRE investors also bought?
            GYRE Investors also bought CHPT, MARA, PLUG, RIOT, CHRS, AMC, BLNK, MRK, GE, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              LCTXLineage Therap
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis